{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:51:25Z","timestamp":1710377485097},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,13]]},"DOI":"10.7759\/cureus.56102","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T17:08:05Z","timestamp":1710349685000},"source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2 with Influenza B Coinfection in a Patient with Sickle Cell HbSC Presenting with Painful Crisis: A Case Report"],"prefix":"10.7759","author":[{"given":"Elrazi A","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdalla","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eihab A","family":"Subahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mugtaba","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Elamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malar","family":"Thwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.925932","article-title":"A case of fulminant liver failure in a 24-year-old man with coinfection with hepatitis B virus and SARS-CoV-2","volume":"21","author":"Ali E","year":"2020","unstructured":"Ali E, Ziglam H, Kohla S, Ahmed M, Yassin M. A case of fulminant liver failure in a 24-year-old man with coinfection with hepatitis B virus and SARS-CoV-2. Am J Case Rep. 2020, 21:e925932. 10.12659\/AJCR.925932","journal-title":"Am J Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4568","article-title":"SARS-CoV-2 and guttate psoriasis: a case report and review of literature","volume":"9","author":"Ali E","year":"2021","unstructured":"Ali E, Mohamed A, Abuodeh J, et al.. SARS-CoV-2 and guttate psoriasis: a case report and review of literature. Clin Case Rep. 2021, 9:e04568. 10.1002\/ccr3.4568","journal-title":"Clin Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3731","article-title":"Severe SARS-CoV-2 infection presenting with acute kidney injury and diabetic ketoacidosis complicated by pancreatitis in a 53-year man with hypertension","volume":"9","author":"Ali E","year":"2021","unstructured":"Ali E, Badawi M, Ahmed A, Abdelmahmuod E, Ibrahim W. Severe SARS-CoV-2 infection presenting with acute kidney injury and diabetic ketoacidosis complicated by pancreatitis in a 53-year man with hypertension. Clin Case Rep. 2021, 9:1202-6. 10.1002\/ccr3.3731","journal-title":"Clin Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i3.10214","article-title":"Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: a comparative study","volume":"91","author":"Soliman AT","year":"2020","unstructured":"Soliman AT, Prabhakaran Nair A, Al Masalamani MS, et al.. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: a comparative study. Acta Biomed. 2020, 91:e2020010. 10.23750\/abm.v91i3.10214","journal-title":"Acta Biomed"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i4.10540","article-title":"Prevalence, clinical manifestations, and biochemical data of hypertensive versus normotensive symptomatic patients with COVID- 19: a comparative study","volume":"91","author":"De Sanctis V","year":"2020","unstructured":"De Sanctis V. Prevalence, clinical manifestations, and biochemical data of hypertensive versus normotensive symptomatic patients with COVID- 19: a comparative study. Acta Biomed. 2020, 91:e2020164. 10.23750\/abm.v91i4.10540","journal-title":"Acta Biomed"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1280271","article-title":"SARS-CoV-2 and chronic myeloid leukemia: a systematic review","volume":"10","author":"Ali EA","year":"2023","unstructured":"Ali EA, Al-Sadi A, Al-Maharmeh Q, et al.. SARS-CoV-2 and chronic myeloid leukemia: a systematic review. Front Med (Lausanne). 2023, 10:1280271. 10.3389\/fmed.2023.1280271","journal-title":"Front Med (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-1465","article-title":"Burden of influenza-related hospitalizations among children with sickle cell disease","volume":"125","author":"Bundy DG","year":"2010","unstructured":"Bundy DG, Strouse JJ, Casella JF, Miller MR. Burden of influenza-related hospitalizations among children with sickle cell disease. Pediatrics. 2010, 125:234-43. 10.1542\/peds.2009-1465","journal-title":"Pediatrics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102330","article-title":"COVID-19 outcomes in patients with sickle cell disease and sickle cell trait compared with individuals without sickle cell disease or trait: a systematic review and meta-analysis","volume":"66","author":"Michelon I","year":"2023","unstructured":"Michelon I, Vilbert M, Pinheiro IS, et al.. COVID-19 outcomes in patients with sickle cell disease and sickle cell trait compared with individuals without sickle cell disease or trait: a systematic review and meta-analysis. EClinicalMedicine. 2023, 66:102330. 10.1016\/j.eclinm.2023.102330","journal-title":"EClinicalMedicine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3548-0","article-title":"The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09","volume":"18","author":"MacIntyre CR","year":"2018","unstructured":"MacIntyre CR, Chughtai AA, Barnes M, Ridda I, Seale H, Toms R, Heywood A. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09. BMC Infect Dis. 2018, 18:637. 10.1186\/s12879-018-3548-0","journal-title":"BMC Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.04.015","article-title":"ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome","volume":"53","author":"Devaux CA","year":"2020","unstructured":"Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. 2020, 53:425-35. 10.1016\/j.jmii.2020.04.015","journal-title":"J Microbiol Immunol Infect"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa093","article-title":"The role of angiotensin-converting enzyme 2 in coronaviruses\/influenza viruses and cardiovascular disease","volume":"116","author":"Chen L","year":"2020","unstructured":"Chen L, Hao G. The role of angiotensin-converting enzyme 2 in coronaviruses\/influenza viruses and cardiovascular disease. Cardiovasc Res. 2020, 116:1932-6. 10.1093\/cvr\/cvaa093","journal-title":"Cardiovasc Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5934","article-title":"SARS-CoV-2 omicron variant may present with severe sickle cell painful crisis: a report of two cases","volume":"10","author":"Ali E","year":"2022","unstructured":"Ali E, Hatim A, Yassin M. SARS-CoV-2 omicron variant may present with severe sickle cell painful crisis: a report of two cases. Clin Case Rep. 2022, 10:e05934. 10.1002\/ccr3.5934","journal-title":"Clin Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23863","article-title":"SARS-CoV-2 Omicron variant in patients with chronic myeloid leukemia: a retrospective study","volume":"14","author":"Ali EA","year":"2022","unstructured":"Ali EA, Khamees I, Abu-Tineh M, et al.. SARS-CoV-2 Omicron variant in patients with chronic myeloid leukemia: a retrospective study. Cureus. 2022, 14:e23863. 10.7759\/cureus.23863","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000525750","article-title":"Severe acute respiratory syndrome coronavirus 2 omicron variant in patients with philadelphia-negative myeloproliferative neoplasm: a single center experience","volume":"100","author":"Ali EA","year":"2022","unstructured":"Ali EA, Khamees I, Alshurafa A, et al.. Severe acute respiratory syndrome coronavirus 2 omicron variant in patients with philadelphia-negative myeloproliferative neoplasm: a single center experience. Oncology. 2022, 100:460-6. 10.1159\/000525750","journal-title":"Oncology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25196","article-title":"A case series of SARS-CoV-2 Omicron variant in patients with acute leukemia","volume":"14","author":"Ali EA","year":"2022","unstructured":"Ali EA, Alamin MA, Abu-Tineh M, Ahmed K, Alshurafa A, Rozi W, Yassin MA. A case series of SARS-CoV-2 Omicron variant in patients with acute leukemia. Cureus. 2022, 14:e25196. 10.7759\/cureus.25196","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32041","article-title":"SARS-CoV-2 Omicron variant in patients with chronic lymphocytic leukemia: case series","volume":"14","author":"Khamees I","year":"2022","unstructured":"Khamees I, Ali EA, Malkawi L, Rozi W, Yassin MA. SARS-CoV-2 Omicron variant in patients with chronic lymphocytic leukemia: case series. Cureus. 2022, 14:e32041. 10.7759\/cureus.32041","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-53045-3.00033-7","article-title":"Hemoglobinopathies (structural defects in hemoglobin)","author":"Randolph TR","year":"2019","unstructured":"Randolph TR. Hemoglobinopathies (structural defects in hemoglobin). Rodak\u2019s Hematology: Clinical Principles and Application. Elsevier, St Louis, MO; 2019. 394-423. 10.1016\/B978-0-323-53045-3.00033-7"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31052-7","article-title":"SARS-CoV-2 and influenza virus co-infection","volume":"395","author":"Cuadrado-Pay\u00e1n E","year":"2020","unstructured":"Cuadrado-Pay\u00e1n E, Montagud-Marrahi E, Torres-Elorza M, et al.. SARS-CoV-2 and influenza virus co-infection. Lancet. 2020, 395:e84. 10.1016\/S0140-6736(20)31052-7","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26125","article-title":"Influenza and COVID-19 coinfection: report of six cases and review of the literature","volume":"92","author":"Ozaras R","year":"2020","unstructured":"Ozaras R, Cirpin R, Duran A, et al.. Influenza and COVID-19 coinfection: report of six cases and review of the literature. J Med Virol. 2020, 92:2657-65. 10.1002\/jmv.26125","journal-title":"J Med Virol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.681469","article-title":"COVID-19 and influenza co-infection: a systematic review and meta-analysis","volume":"8","author":"Dadashi M","year":"2021","unstructured":"Dadashi M, Khaleghnejad S, Abedi Elkhichi P, et al.. COVID-19 and influenza co-infection: a systematic review and meta-analysis. Front Med (Lausanne). 2021, 8:681469. 10.3389\/fmed.2021.681469","journal-title":"Front Med (Lausanne)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-021-01594-0","article-title":"Influenza co-infection associated with severity and mortality in COVID-19 patients","volume":"18","author":"Alosaimi B","year":"2021","unstructured":"Alosaimi B, Naeem A, Hamed ME, et al.. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virol J. 2021, 18:127. 10.1186\/s12985-021-01594-0","journal-title":"Virol J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac071","article-title":"SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes","volume":"1","author":"Pawlowski C","year":"2022","unstructured":"Pawlowski C, Silvert E, O'Horo JC, et al.. SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes. PNAS Nexus. 2022, 1:pgac071. 10.1093\/pnasnexus\/pgac071","journal-title":"PNAS Nexus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004093","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis","volume":"48","author":"Lansbury LE","year":"2020","unstructured":"Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Shen Lim W. Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis. Crit Care Med. 2020, 48:e98-e106. 10.1097\/CCM.0000000000004093","journal-title":"Crit Care Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174579","article-title":"Use of steroids in COVID-19 patients: a meta-analysis","volume":"914","author":"Thakur M","year":"2022","unstructured":"Thakur M, Datusalia AK, Kumar A. Use of steroids in COVID-19 patients: a meta-analysis. Eur J Pharmacol. 2022, 914:174579. 10.1016\/j.ejphar.2021.174579","journal-title":"Eur J Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq015","article-title":"Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations","volume":"65 Suppl 2","author":"Davies BE","year":"2010","unstructured":"Davies BE. Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations. J Antimicrob Chemother. 2010, 65 Suppl 2:ii5-10. 10.1093\/jac\/dkq015","journal-title":"J Antimicrob Chemother"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7341493","article-title":"Paxlovid: mechanism of action, synthesis, and in silico study","volume":"2022","author":"Marzi M","year":"2022","unstructured":"Marzi M, Vakil MK, Bahmanyar M, Zarenezhad E. Paxlovid: mechanism of action, synthesis, and in silico study. Biomed Res Int. 2022, 2022:7341493. 10.1155\/2022\/7341493","journal-title":"Biomed Res Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/231999-sars-cov-2-with-influenza-b-coinfection-in-a-patient-with-sickle-cell-hbsc-presenting-with-painful-crisis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T17:08:10Z","timestamp":1710349690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/231999-sars-cov-2-with-influenza-b-coinfection-in-a-patient-with-sickle-cell-hbsc-presenting-with-painful-crisis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.56102","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,13]]}}}